NEW YORK, Aug. 11, 2025 (GLOBE NEWSWIRE) -- IO Biotech (Nasdaq: IOBT) today announces topline results from the pivotal Phase 3 trial of its investigational, immune-modulatory, off-the-shelf ...

Addicting Games has acquired Mope.io, a web and mobile survival game with more than 72 million players to date. The move is part of a revival for Addicting Games, which has followed a winding road but ...

To all fans of battle ground is dedicated: War.io Survival Battle Royale - this is a huge fight in the deathmatch mode. A new 2d top-down shooter takes you to a world where you have to fight for your ...

Patients treated with Cylembio (imsapepimut and etimupepimut, adjuvanted) plus pembrolizumab achieved improvement in progression free survival (PFS) compared to patients treated with pembrolizumab ...